Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_1724222
Proper Citation: (Novus Cat# NB100-2672C, RRID:AB_1724222)
Target Antigen: Human CD15
Host Organism: mouse
Clonality: monoclonal
Comments: validation status unknown, reseller suggested use: Flow Cytometry; Immunohistochemistry; Immunoprecipitation; flow cytometry / FACS analysis, immunohistochemistry, Immunohistochemistry-Frozen, immunoprecipitation
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
Check
for all resource mentions.
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Mouse Anti-Human CD15 Monoclonal, Dylight 649 Conjugated, Clone 28.
Possibly Non-Specific
Extracted Antibody Information: "FACS labeling: endogenous GFP signal from Atoh1-GFP KI mice, anti-CD15-Dylight649 (1:50, Novus, Novus Biologicals, Littleton, CO Cat# NB100-2672C RRID:AB_1724222);"
Extracted Specificity Statement: "We further confirmed these findings in tumorigenic and control tissues from mice and found that Atoh1 Y78 phosphorylation is specific to the tumor-initiating cells (Figure 1c). Y78 immuno-reactivity was observed mostly in the initiating cell islets of the tumor; neither the Y78-specific phospho-antibody, nor an antibody against CD15, reacted in the normal tissue, even in the presence of strong Atoh1 expression in the external granule layer (Figure 1c)."
Data was mined by Antibody Watch (https://arxiv.org/pdf/2008.01937.pdf), from PMID:29168692
Source: Antibody Registry
